Dr. Leong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 Duarte Rd
Duarte, CA 91010Phone+1 626-359-8111Fax+1 626-408-3911
Education & Training
- City of Hope National Medical CenterFellowship, Hematology and Medical Oncology, 1983 - 1985
- Los Angeles County-Harbor-UCLA Medical Center 1Fellowship, Hematology and Medical Oncology, 1982 - 1983
- Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1979 - 1982
- Stanford University School of MedicineClass of 1979
Certifications & Licensure
- CA State Medical License 1981 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Hospice and Palliative MedicinePalliative Medicine
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2014
- Top Doctors:LA Area Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2013
- Join now to see all
Clinical Trials
- Liver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating Patients With Liver Metastases From Colorectal Cancer Start of enrollment: 1994 Sep 01
Publications & Presentations
PubMed
- 60 citationsAnal carcinoma, version 2.2012: Featured updates to the NCCN guidelinesAl B. Benson, J. Pablo Arnoletti, Tanios Bekaii-Saab, Emily Chan, Yi Jen Chen
Journal of the National Comprehensive Cancer Network. 2012-04-01 - 179 citationsA phase II trial of vorinostat (suberoylanilide hydroxamic acid) in metastatic breast cancer: a California Cancer Consortium study.Thehang Luu, Robert J. Morgan, Lucille Leong, Dean Lim, Mark McNamara
Clinical Cancer Research. 2008-11-01 - 35 citationsPhase II study of oxaliplatin in patients with unresectable, metastatic, or recurrent hepatocellular cancer: a California Cancer Consortium Trial.Yun Yen, Dean W. Lim, Vincent Chung, Robert J. Morgan, Lucille Leong
American Journal of Clinical Oncology. 2008-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: